HMGB1 and neoplasm: Such immunogenic features of irradiation-driven cell death are bolstered by several pivotal factors including the release of High-Mobility Group Protein B1 (HMGB1), the emission of adenosine-triphosphate (ATP), and the exposure of Calreticulin (CRT) on the tumor cell surface 37-42.